Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Indometacin 50mg capsules
1001010K0AAABAB
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 15,034 |
|
Indometacin 25mg capsules
1001010K0AAAAAA
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 10,548 |
|
Indometacin 100mg suppositories
1001010K0AAAFAF
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 499 |
|
Indometacin 25mg/5ml oral suspension
1001010K0AABBBB
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 167 |
|
Indometacin 75mg modified-release capsules
1001010K0AAADAD
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 64 |
|
Indometacin 25mg/5ml oral solution
1001010K0AAAQAQ
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 21 |
|
Indometacin 5mg/5ml oral liquid
1001010K0AABABA
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 4 |
|
Indometacin 10mg/5ml oral liquid
1001010K0AAAXAX
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 1 |
|
Indometacin 75mg modified-release tablets
1001010K0AAAJAJ
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 1 |
|
Indometacin 1.2mg/5ml oral liquid
1001010K0AAATAT
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 12mg/5ml oral liquid
1001010K0AAAYAY
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 15mg/5ml oral liquid
1001010K0AAAZAZ
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 20mg/5ml oral liquid
1001010K0AAARAR
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 25mg modified-release capsules
1001010K0AAACAC
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 25mg modified-release tablets
1001010K0AAALAL
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 25mg/5ml oral suspension sugar free
1001010K0AAAEAE
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 31.25mg/5ml oral liquid
1001010K0AAAWAW
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 3mg/5ml oral liquid
1001010K0AAASAS
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 500micrograms/5ml oral liquid
1001010K0AAAUAU
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 50mg modified-release tablets
1001010K0AAAKAK
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 50mg/5ml oral liquid
1001010K0AAAVAV
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.